# Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder

> **NCT06693609** · PHASE2 · COMPLETED · sponsor: **atai Therapeutics, Inc.** · enrollment: 70 (actual)

## Conditions studied

- Social Anxiety Disorder

## Interventions

- **DRUG:** EMP-01
- **DRUG:** EMP-01 Placebo

## Key facts

- **NCT ID:** NCT06693609
- **Lead sponsor:** atai Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-15
- **Primary completion:** 2026-02-12
- **Final completion:** 2026-02-12
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06693609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06693609, "Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06693609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*